Madrigal Pharmaceuticals, Inc. (MDGL)
499.40
-0.31
(-0.06%)
USD |
NASDAQ |
Oct 02, 16:00
499.58
+0.18
(+0.04%)
After-Hours: 20:00
Madrigal Pharmaceuticals Market Cap : 11.53B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 11.53B |
| October 01, 2026 | 11.54B |
| September 30, 2026 | 11.64B |
| September 29, 2026 | 11.77B |
| September 28, 2026 | 11.94B |
| September 25, 2026 | 11.93B |
| September 24, 2026 | 11.85B |
| September 23, 2026 | 11.85B |
| September 22, 2026 | 11.98B |
| September 21, 2026 | 12.05B |
| September 18, 2026 | 12.27B |
| September 17, 2026 | 12.34B |
| September 16, 2026 | 12.22B |
| September 15, 2026 | 12.08B |
| September 14, 2026 | 12.47B |
| September 11, 2026 | 12.34B |
| September 10, 2026 | 12.31B |
| September 09, 2026 | 12.62B |
| September 08, 2026 | 12.34B |
| September 04, 2026 | 12.50B |
| September 03, 2026 | 12.53B |
| September 02, 2026 | 12.63B |
| September 01, 2026 | 12.44B |
| August 31, 2026 | 12.47B |
| August 28, 2026 | 12.33B |
| Date | Value |
|---|---|
| August 27, 2026 | 12.56B |
| August 26, 2026 | 12.44B |
| August 25, 2026 | 11.83B |
| August 24, 2026 | 11.82B |
| August 21, 2026 | 11.93B |
| August 20, 2026 | 11.99B |
| August 19, 2026 | 12.47B |
| August 18, 2026 | 12.11B |
| August 17, 2026 | 12.12B |
| August 14, 2026 | 11.72B |
| August 13, 2026 | 11.72B |
| August 12, 2026 | 12.38B |
| August 11, 2026 | 12.36B |
| August 10, 2026 | 11.90B |
| August 07, 2026 | 11.78B |
| August 06, 2026 | 11.79B |
| August 05, 2026 | 11.87B |
| August 04, 2026 | 11.72B |
| August 03, 2026 | 11.13B |
| July 31, 2026 | 10.79B |
| July 30, 2026 | 11.39B |
| July 29, 2026 | 12.63B |
| July 28, 2026 | 12.44B |
| July 27, 2026 | 12.73B |
| July 24, 2026 | 12.55B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Exelixis, Inc. | 14.53B |
| Insmed, Inc. | 24.26B |
| United Therapeutics Corp. | 23.12B |
| Karyopharm Therapeutics, Inc. | 18.19M |
Market Cap Related Metrics
| PS Ratio | 10.06 |
| PEG Ratio | -136.06 |
| Price to Book Value | 22.02 |
| Price | 499.40 |
| Earnings Yield | -2.58% |
| PEGY Ratio | -136.06 |